Sartorius (OTCMKTS:SARTF – Get Free Report) reached a new 52-week high during trading on Friday . The stock traded as high as $228.0150 and last traded at $228.0150, with a volume of 5 shares trading hands. The stock had previously closed at $192.43.
Sartorius Stock Performance
The stock has a market cap of $7.80 billion, a P/E ratio of 106.05 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49. The firm’s 50-day moving average price is $212.80 and its 200-day moving average price is $216.33.
Sartorius Company Profile
Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services for pharmaceutical, biotechnology and laboratory applications. Its offerings support the development, production and quality control of medicines, vaccines and other biological products.
The company’s products include laboratory instruments, balances, filtration systems, laboratory consumables, bioreactors, cell-culture technologies, fluid-management systems, sensors and analytical equipment.
Featured Stories
- Five stocks we like better than Sartorius
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.
